Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome (Q46564996)

23 December 2017

title

Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome (English)

1 reference

23 December 2017

main subject

azithromycin

0 references

bronchiolitis

0 references

bronchiolitis obliterans

1 reference

Bryan Yates

1 reference

23 December 2017

Desmond M Murphy

1 reference

23 December 2017

Ian A Forrest

1 reference

23 December 2017

Chris Ward

1 reference

23 December 2017

Robert M Rutherford

1 reference

23 December 2017

Andrew J Fisher

1 reference

23 December 2017

James L Lordan

1 reference

23 December 2017

John H Dark

1 reference

23 December 2017

Paul A Corris

1 reference

23 December 2017

language of work or name

English

0 references

publication date

23 June 2005

1 reference

23 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

23 December 2017

volume

172

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

772-775

1 reference

23 December 2017

cites work

Lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Obliterative bronchiolitis after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Lung transplantation. Bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

The Registry of the International Society for Heart and Lung Transplantation: past, present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

New immunosuppressive regimens in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Macrolides for the treatment of chronic sinusitis, asthma, and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Macrolides Inhibit Epithelial Cell–Mediated Neutrophil Survival by Modulating Granulocyte Macrophage Colony–Stimulating Factor Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Bronchiolitis obliterans after human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1537OC

10.1164/RCCM.200411-1537OC

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017